查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886061

全球免疫血液學儀器與試劑市場

Immunohematology Analyzers and Reagents
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球免疫血液分析儀和試劑市場預計2030年將達33億美元

全球免疫血液分析儀及試劑市場規模在2024年估計為25億美元，預計到2030年將達到33億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為4.7%。試劑是本報告分析的細分市場之一，預計在分析期結束時複合年成長率將達到4.2%，市場規模將達到23億美元。分析儀細分市場預計在分析期間內複合年成長率將達到5.8%。

美國市場規模估計為6.788億美元，而中國市場預計將以4.5%的複合年成長率成長。

預計2024年，美國免疫血液分析儀及試劑市場規模將達6.788億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5.19億美元，2024年至2030年的複合年成長率（CAGR）為4.5%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率將分別達到4.3%和3.9%。在歐洲，德國的複合年成長率預計將達到約4.7%。

全球免疫血液分析儀和試劑市場—主要市場趨勢和促進因素概述

免疫血液分析儀和試劑如何確保輸血安全？

免疫血液分析儀和試劑在輸血醫學領域至關重要，在確保輸血的安全性和相容性方面發揮核心作用。這些先進的儀器和化學試劑用於檢測血液樣本中的重要標記物，例如血型、Rh因子以及某些可能在輸血過程中引起不良反應的抗體。例如，血型鑑定對於確定捐血和受血者的相容性至關重要。免疫血液分析儀可自動完成此過程，檢測並辨識紅血球表面的抗原（例如A、B、RhD），幫助醫療團隊準確判斷捐血與受血者免疫系統的相容性。

除了血型鑑定外，免疫血液學試劑也用於識別可能因先前輸血、懷孕或自體免疫疾病而產生的異常抗體。如果在輸血前未能檢測到這些抗體，則可能引起溶血反應，即身體攻擊輸注的紅血球，導致危及生命的併發症。先進的免疫學技術，例如凝集試驗、酵素免疫分析法(ELISA) 和微柱凝膠技術，使分析儀能夠準確檢測出即使是微量的此類抗體。免疫血液學分析儀和試劑提供快速、準確和自動化的檢測，確保輸血的安全性和成功率，最終在急診和常規臨床環境中挽救生命。

為什麼免疫血液分析儀和試劑在疾病檢測和血液管理中如此重要？

免疫血液分析儀和試劑的作用遠不止於輸血安全。它們對於診斷血液相關疾病以及治療影響免疫系統和血液學的疾病也至關重要。其中一個最重要的應用是檢測和治療新生兒溶血病（HDN）。在HDN中，母體抗體會攻擊胎兒的紅血球，導致貧血和其他併發症。專業的免疫血液學試劑使醫護人員能夠檢測抗D抗體和其他相關標記物，從而實現早期干預和治療，包括透過注射Rh免疫球蛋白來預防HDN。

免疫血液學技術在自體免疫溶血性貧血的治療中也扮演著至關重要的角色。自體免疫性溶血性貧血是一種自體免疫系統錯誤地破壞紅血球的疾病。透過識別攻擊患者血液的自身抗體，這些系統有助於確定合適的治療方案，例如免疫抑制療法和輸注相容性血液。此外，在骨髓移植等複雜的醫療過程中，使用這些分析儀進行精確的血型匹配檢測至關重要，以避免移植物抗宿主疾病（GVHD）的發生。在GVHD中，移植的細胞可能會攻擊宿主的身體。

此外，免疫血液學試劑也用於後續觀察接受長期治療的患者，例如慢性貧血患者或接受化療的癌症患者。常規血液檢測對於評估免疫功能和整體血液健康至關重要。免疫血液學分析儀的自動化功能可確保高通量和準確的結果，這對於疾病的持續管理至關重要。隨著免疫和血液疾病的日益複雜，這些系統已成為臨床醫生不可或缺的工具，有助於有效診斷、監測和管理各種血液疾病。

免疫血液分析儀如何推動檢查室創新？

免疫血液分析儀處於檢查室自動化的前沿，透過簡化工作流程和提高檢測準確性，徹底改變了血庫和臨床檢查室的運作方式。該領域的一項重大進展是將自動化和機器人技術整合到免疫血液系統中，從而實現了血液樣本的高通量處理。現代分析儀每天能夠處理數百個檢體，且只需極少的人工干預，從而降低了人為錯誤的風險，並確保了檢測流程的標準化。這對於大型醫院和血庫尤其重要，因為這些機構對血液製品的需求持續不斷，快速可靠的檢測結果對患者照護至關重要。

將先進的軟體和數據管理工具整合到免疫血液分析儀中，大大提高了檢查室效率。這些系統現在可以與醫院資訊系統 (HIS) 和實驗室資訊管理系統 (LIMS) 整合，從而實現不同部門之間的無縫資訊共用。這種連接性使得檢測結果能夠即時共用給醫護人員，並加快臨床決策過程，尤其是在分秒必爭的緊急情況下。此外，人工智慧 (AI) 和機器學習演算法的不斷發展，透過學習大量資料集，進一步提高了分析儀的準確性，增強了其預測和檢測可能被忽略的罕見抗體的能力。

另一個大趨勢是免疫血液學系統的微型化，使得就地檢驗在更多環境下成為現實。採用微流體技術的攜帶式分析儀的問世，即使在偏遠和資源匱乏的地區，也能實現快速的現場血液檢測。這些進步顯著提高了免疫血液學檢測的可及性和速度，確保在需要時隨時隨地提供高品質、可靠的診斷。隨著技術的不斷發展，免疫血液學分析儀仍將是實驗室醫學轉型的重要組成部分，協助建構更有效率、更精準、更快速反應的醫療保健系統。

哪些因素正在推動免疫血液分析儀和試劑市場的成長？

免疫血液分析儀和試劑市場的成長受多種關鍵因素驅動，這些因素共同推動了對這些技術的需求不斷成長。其中一個關鍵促進因素是全球輸血需求的日益成長。隨著人口老化、癌症和貧血等慢性疾病的流行以及複雜手術的增加，對安全且相容的血液製品的需求持續成長。免疫血液分析儀透過提供快速且準確的血型鑑定和抗體篩檢來確保輸血安全，從而促進了其在全球醫院、血庫和診所的應用。

另一個關鍵因素是自動化在臨床檢查室中日益成長的重要性。隨著檢查室面臨越來越大的壓力，需要在處理更大樣本量的同時提供更快、更準確的結果，現代免疫血液分析儀的自動化功能變得至關重要。這些系統不僅減少了人工勞動，最大限度地減少了人為錯誤，還能實現連續、高通量的檢測，以滿足現代醫療環境的需求。在醫療基礎設施完善的已開發國家，這種趨勢尤其明顯，因為大規模血液檢測已成為常規需求。

免疫血液學試劑的技術進步也推動了市場成長。更具特異性、靈敏度和穩定性的試劑的開發提高了血液檢測的性能，增強了對罕見抗體和抗原的檢測準確性。這些創新拓展了免疫血液學檢測的效用，使其不僅適用於常規檢測，也適用於自體免疫疾病和罕見血型等複雜病例。此外，個人化醫療的興起和對精準診斷日益成長的關注也推動了對先進免疫血液學技術的需求。這些技術能夠提供製定個人化治療方案所需的詳細分子資訊。

最後，監管支持的加強和公眾對安全輸血重要性的認知提高也是市場擴張的推動因素。各國政府和醫療機構正在實施嚴格的指導方針和措施來提高輸血安全性，這促使免疫血液分析儀和試劑的使用量不斷成長。隨著這一趨勢的持續，在日益複雜的醫療環境中，對自動化和高精度血液檢測的需求不斷增加，預計免疫血液學市場將顯著成長。

部分：

依產品（試劑、分析設備）、技術（聚合酵素鏈鎖反應、凝膠卡、生物晶片、紅血球磁化、微孔盤）、應用（醫院、診斷和參考檢查室、血庫、學術和研究機構）分類

受訪公司範例

  • Immucor, Inc.
  • Merck &Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用典型的 LLM 或產業專用的SLM 方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP12535

Global Immunohematology Analyzers and Reagents Market to Reach US$3.3 Billion by 2030

The global market for Immunohematology Analyzers and Reagents estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$678.8 Million While China is Forecast to Grow at 4.5% CAGR

The Immunohematology Analyzers and Reagents market in the U.S. is estimated at US$678.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$519.0 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Immunohematology Analyzers and Reagents Market - Key Trends and Drivers Summarized

How Do Immunohematology Analyzers and Reagents Work to Ensure Safe Blood Transfusions?

Immunohematology analyzers and reagents are vital in the field of transfusion medicine, playing a central role in ensuring the safety and compatibility of blood transfusions. These sophisticated devices and chemicals are used to test blood samples for key markers, such as blood type, Rh factor, and the presence of specific antibodies that could cause adverse reactions during transfusions. Blood typing, for example, is crucial in matching donors and recipients. Immunohematology analyzers automate this process, detecting and identifying antigens (like A, B, and RhD) on the surface of red blood cells, helping medical teams to accurately determine the compatibility between donated blood and the recipient's immune system.

In addition to blood typing, immunohematology reagents are used to identify irregular antibodies that can form due to previous transfusions, pregnancy, or autoimmune conditions. These antibodies can cause hemolytic reactions if not detected before a transfusion, where the body attacks transfused red blood cells, potentially leading to life-threatening complications. Through advanced immunological techniques like agglutination, enzyme-linked immunosorbent assays (ELISA), and microcolumn gel technology, analyzers can precisely identify even low levels of these antibodies. By providing fast, accurate, and automated testing, immunohematology analyzers and reagents ensure the safety and success of blood transfusions, ultimately saving lives in both emergency and routine clinical settings.

Why Are Immunohematology Analyzers and Reagents Crucial in Disease Detection and Blood Management?

Immunohematology analyzers and reagents go far beyond transfusion safety-they are also essential in diagnosing blood-related disorders and managing diseases that affect the immune and hematologic systems. One of the most critical applications is in the detection and management of hemolytic diseases of the newborn (HDN), where a mother's antibodies attack the fetus’s red blood cells, leading to anemia and other complications. Through the use of specialized immunohematology reagents, healthcare professionals can detect anti-D antibodies and other relevant markers, allowing for early intervention and treatment, such as administering Rh immunoglobulin to prevent HDN.

Immunohematology technologies also play a pivotal role in managing autoimmune hemolytic anemia, a condition where the immune system mistakenly destroys red blood cells. By identifying autoantibodies that are attacking the patient’s blood, these systems help guide appropriate treatment, such as immunosuppressive therapy or the administration of compatible blood transfusions. Furthermore, in complex medical procedures like bone marrow transplants, accurate blood matching facilitated by these analyzers is crucial to avoid graft-versus-host disease, where the transplanted cells may attack the host’s body.

Additionally, immunohematology reagents are used to monitor patients undergoing long-term therapies, such as those with chronic anemia or cancer patients receiving chemotherapy, where regular blood testing is necessary to assess immune function and overall blood health. The automation provided by immunohematology analyzers ensures high-throughput, precise results that are critical for ongoing disease management. As the complexity of immunological and hematological conditions continues to grow, these systems provide indispensable tools for clinicians, helping to diagnose, monitor, and manage a wide array of blood disorders effectively.

How Are Immunohematology Analyzers Driving Technological Innovation in Laboratories?

Immunohematology analyzers are at the forefront of laboratory automation, revolutionizing the way blood banks and clinical labs operate by streamlining workflows and increasing testing accuracy. One of the key advancements in this field is the integration of automation and robotics within immunohematology systems, allowing for high-throughput processing of blood samples. Modern analyzers can process hundreds of samples per day with minimal human intervention, reducing the risk of human error and ensuring standardized testing procedures. This is especially important in large hospitals and blood banks where the demand for blood products is constant, and rapid, reliable results are critical for patient care.

The incorporation of advanced software and data management tools into immunohematology analyzers has also transformed laboratory efficiency. These systems are now capable of integrating with hospital information systems (HIS) and laboratory information management systems (LIMS), allowing for seamless communication between different departments. This connectivity enables real-time sharing of test results with healthcare providers, speeding up clinical decision-making processes, particularly in emergencies where time is of the essence. Additionally, artificial intelligence and machine learning algorithms are being developed to further enhance the precision of these analyzers, by learning from vast datasets to predict and detect rare antibodies that might otherwise go unnoticed.

Another major trend is the miniaturization of immunohematology systems, making point-of-care testing a reality in more settings. Portable analyzers equipped with microfluidic technologies are being introduced, enabling fast, on-site blood testing even in remote or resource-limited environments. These advances are drastically improving the accessibility and speed of immunohematology testing, ensuring that high-quality, reliable diagnostics are available where and when they are needed. As technology continues to evolve, immunohematology analyzers will remain integral to the transformation of laboratory medicine, leading to more efficient, accurate, and responsive healthcare systems.

What’s Driving the Growth in the Immunohematology Analyzer and Reagent Market?

The growth in the immunohematology analyzer and reagent market is driven by several critical factors, each contributing to the increasing demand for these technologies. One of the primary drivers is the rising need for blood transfusions globally. With an aging population, the prevalence of chronic diseases, such as cancer and anemia, and an increasing number of complex surgeries, the demand for safe and compatible blood products continues to grow. Immunohematology analyzers ensure that blood transfusions are safe by providing rapid and accurate blood typing and antibody screening, which has fueled their adoption across hospitals, blood banks, and clinics worldwide.

Another significant factor is the growing emphasis on automation in clinical laboratories. As labs face increasing pressure to deliver faster, more accurate results while managing higher volumes of tests, the automation capabilities of modern immunohematology analyzers are becoming indispensable. These systems not only reduce manual labor and minimize human error but also allow for continuous, high-throughput testing that meets the demands of modern healthcare environments. This trend is particularly evident in developed countries with well-established healthcare infrastructures, where large-scale blood testing is a daily requirement.

Technological advancements in immunohematology reagents are also contributing to market growth. The development of more specific, sensitive, and stable reagents has enhanced the performance of blood tests, leading to improved detection of rare antibodies and antigens. These innovations have expanded the utility of immunohematology assays in both routine testing and complex cases, such as those involving autoimmune disorders or rare blood types. Furthermore, the rise of personalized medicine and the increasing focus on precision diagnostics are driving demand for advanced immunohematology technologies, which offer the detailed molecular insights needed for tailored treatment plans.

Finally, regulatory support and increasing public awareness about the importance of safe blood transfusions have also played a role in market expansion. Governments and healthcare organizations are implementing stringent guidelines and initiatives to improve transfusion safety, which has led to higher adoption rates of immunohematology analyzers and reagents. As these trends continue, the immunohematology market is poised for substantial growth, driven by the rising need for automated, high-precision blood testing in an increasingly complex healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Immunohematology Analyzers and Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents, Analyzers); Technology (Polymerase Chain Reaction, Gel Cards, Biochips, Erythrocyte-Magnetized, Microplates); End-Use (Hospitals, Diagnostic & Reference Laboratories, Blood Banks, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • Immucor, Inc.
  • Merck & Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Immunohematology Analyzers and Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Transfusions Drives Growth in Immunohematology Analyzers and Reagents Market
    • Expansion of Blood Bank Services Spurs Adoption of Immunohematology Analyzers
    • Increasing Focus on Fully Automated and High-throughput Immunohematology Analyzers Fuels Market Demand
    • Growth in Use of Immunohematology in Crossmatching and Compatibility Testing Expands Market Opportunities
    • Growth in Demand for Immunohematology Analyzers in Hospital Laboratories Fuels Market Expansion
    • Increasing Focus on Immunohematology for Rare Blood Group Detection Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Immunohematology Analyzers and Reagents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gel cards by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Erythrocyte-Magnetized by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic & Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION